W M Bennett

Summary

Affiliation: Legacy Health System
Country: USA

Publications

  1. ncbi request reprint Cyclosporine nephrotoxicity
    Emmanuel A Burdmann
    Division of Nephrology, Sao Jose do Rio Preto Medical School, Sao Jose do Rio Preto, Brazil
    Semin Nephrol 23:465-76. 2003
  2. ncbi request reprint Morbid obesity does not preclude successful renal transplantation
    William M Bennett
    Solid Organ and Cellular Transplantation, Legacy Good Samaritan Hospital, Portland, OR 97210 3025, USA
    Clin Transplant 18:89-93. 2004
  3. ncbi request reprint Renal transplantation for ADPKD patients: a 2007 update
    William M Bennett
    Legacy Transplant Services, Portland, OR, USA
    Nephrol News Issues 21:24-5, 27. 2007
  4. doi request reprint Reporting eGFR
    William M Bennett
    Northwest Renal Clinic, Portland, Oregon, USA
    Clin J Am Soc Nephrol 3:1561-2. 2008
  5. pmc Autosomal dominant polycystic kidney disease: 2009 update for internists
    William M Bennett
    Northwest Renal Clinic, Transplant Services Legacy Good Samaritan Hospital, Portland, OR 97210, USA
    Korean J Intern Med 24:165-8. 2009
  6. ncbi request reprint Disseminated intravascular coagulation (DIC) in a kidney donor associated with transient recipient DIC
    William M Bennett
    Solid Organ and Cellular Transplantation, Legacy Good Samaritan Hospital, Portland, OR, USA
    Am J Transplant 5:412-4. 2005
  7. ncbi request reprint Use of organs for transplantation from a donor with primary meningoencephalitis due to Naegleria fowleri
    W M Bennett
    Northwest Renal Clinic, Legacy Transplant Services, Portland, OR, USA
    Am J Transplant 8:1334-5. 2008
  8. ncbi request reprint Should dialysis patients ever receive warfarin and for what reasons?
    William M Bennett
    Northwest Renal Clinic, Transplant Services, Legacy Good Samaritan Hospital, Portland, OR 97210, USA
    Clin J Am Soc Nephrol 1:1357-9. 2006
  9. doi request reprint Surveillance and modification of immunosuppression minimizes BK virus nephropathy
    William M Bennett
    Transplant Services, Legacy Good Samaritan Medical Center, Portland, OR 97210, USA
    Am J Nephrol 32:10-2. 2010
  10. doi request reprint Kidney transplantation in the morbidly obese: complicated but still better than dialysis
    William M Bennett
    Legacy Good Samaritan Hospital, Portland, OR, USA
    Clin Transplant 25:401-5. 2011

Collaborators

Detail Information

Publications45

  1. ncbi request reprint Cyclosporine nephrotoxicity
    Emmanuel A Burdmann
    Division of Nephrology, Sao Jose do Rio Preto Medical School, Sao Jose do Rio Preto, Brazil
    Semin Nephrol 23:465-76. 2003
    ..A working hypothesis for the possible mechanisms of chronic cyclosporine nephrotoxicity will be provided...
  2. ncbi request reprint Morbid obesity does not preclude successful renal transplantation
    William M Bennett
    Solid Organ and Cellular Transplantation, Legacy Good Samaritan Hospital, Portland, OR 97210 3025, USA
    Clin Transplant 18:89-93. 2004
    ..Based on our experience, morbid obesity should not be used to exclude patients arbitrarily from transplantation anymore than advanced age or diabetes should...
  3. ncbi request reprint Renal transplantation for ADPKD patients: a 2007 update
    William M Bennett
    Legacy Transplant Services, Portland, OR, USA
    Nephrol News Issues 21:24-5, 27. 2007
  4. doi request reprint Reporting eGFR
    William M Bennett
    Northwest Renal Clinic, Portland, Oregon, USA
    Clin J Am Soc Nephrol 3:1561-2. 2008
  5. pmc Autosomal dominant polycystic kidney disease: 2009 update for internists
    William M Bennett
    Northwest Renal Clinic, Transplant Services Legacy Good Samaritan Hospital, Portland, OR 97210, USA
    Korean J Intern Med 24:165-8. 2009
    ..In the near future, therapies for this common genetic disease may be available to either prevent or stabilize the disease course for many affected individuals...
  6. ncbi request reprint Disseminated intravascular coagulation (DIC) in a kidney donor associated with transient recipient DIC
    William M Bennett
    Solid Organ and Cellular Transplantation, Legacy Good Samaritan Hospital, Portland, OR, USA
    Am J Transplant 5:412-4. 2005
    ....
  7. ncbi request reprint Use of organs for transplantation from a donor with primary meningoencephalitis due to Naegleria fowleri
    W M Bennett
    Northwest Renal Clinic, Legacy Transplant Services, Portland, OR, USA
    Am J Transplant 8:1334-5. 2008
    ..fowleri infection. Kidneys, pancreas, a lung and liver were used with no evidence of posttransplant infectious complications. This unusual cause of brain death does not preclude successful organ donation...
  8. ncbi request reprint Should dialysis patients ever receive warfarin and for what reasons?
    William M Bennett
    Northwest Renal Clinic, Transplant Services, Legacy Good Samaritan Hospital, Portland, OR 97210, USA
    Clin J Am Soc Nephrol 1:1357-9. 2006
  9. doi request reprint Surveillance and modification of immunosuppression minimizes BK virus nephropathy
    William M Bennett
    Transplant Services, Legacy Good Samaritan Medical Center, Portland, OR 97210, USA
    Am J Nephrol 32:10-2. 2010
    ..Infection of a transplanted kidney with the polyomavirus, BK, is associated with poor allograft survival...
  10. doi request reprint Kidney transplantation in the morbidly obese: complicated but still better than dialysis
    William M Bennett
    Legacy Good Samaritan Hospital, Portland, OR, USA
    Clin Transplant 25:401-5. 2011
    ..Thus, there is no a priori ethical reason for treating obese ESRD patients differently from those with other comorbidities...
  11. ncbi request reprint Chronic cyclosporine nephrotoxicity
    T F Andoh
    Department of Medicine, Oregon Health Sciences University, Portland, USA
    Curr Opin Nephrol Hypertens 7:265-70. 1998
    ..Insights gained from experimental models of chronic nephrotoxicity associated with tubulointerstitial fibrosis are presented to elucidate the pathophysiology...
  12. ncbi request reprint Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies
    A J Olyaei
    Division of Nephrology, Hypertension and Clinical Pharmacology, Oregon Health Sciences University and Solid Organ and Cellular Transplantation, Legacy Good Samaritan Hospital, Portland, Oregon 97201, USA
    Curr Opin Crit Care 7:384-9. 2001
    ..New experiences with non-nephrotoxic agents and protocols including mycophenolate and sirolimus allow for early calcineurin inhibitor reduction or elimination without increasing the risk of allograft rejection...
  13. ncbi request reprint Subclinical renal injury induced by transient cyclosporine exposure is associated with salt-sensitive hypertension
    T F Andoh
    Solid Organ Transplant Service, Legacy Good Samaritan Hospital, Portland, OR 97232, USA
    Am J Transplant 1:222-7. 2001
    ..One mechanism by which cyclosporine induces hypertension is the induction of subtle renal microvascular and tubulointerstitial disease. This mechanism is not dependent on GFR and may persist even after the cyclosporine is discontinued...
  14. doi request reprint Enteric oxalate nephropathy in the renal allograft: an underrecognized complication of bariatric surgery
    M L Troxell
    Department of Pathology, Oregon Health and Science University, Portland, OR, USA
    Am J Transplant 13:501-9. 2013
    ..As the incidence of obesity and pretransplant bariatric surgery increases in the transplant population, allograft oxalate nephropathy is likely to be an increasing cause of allograft dysfunction...
  15. ncbi request reprint Use of basiliximab and daclizumab in kidney transplantation
    A J Olyaei
    Oregon Health Sciences University, Portland, Ore, USA
    Prog Transplant 11:33-7; quiz 38-9. 2001
    ..Further studies are needed to evaluate the overall effect of these agents on long-term patient and allograft survival...
  16. ncbi request reprint Increased vascular resistance and not salt retention characterizes cyclosporine A-induced hypertension: report in an anuric patient
    I M Wahba
    Department of Medicine, Division of Nephrology and Hypertension, Oregon Health and Science University, Portland, OR, USA
    Am J Transplant 7:2042-6. 2007
    ..We briefly discuss the possible mechanisms of CsA-induced hypertension in light of this information...
  17. ncbi request reprint Drug-related renal dysfunction in the elderly
    W M Bennett
    Division of Nephrology, Hypertension and Clinical Pharmacology, Oregon Health Sciences University, Portland, USA
    Geriatr Nephrol Urol 9:21-5. 1999
    ..This paper reviews this issue with specific emphasis on drugs that are often used in elderly subjects such as nonsteroidal antiinflammatory agents, angiotension converting enzyme inhibitors, antibiotics, and immunosuppressive drugs...
  18. ncbi request reprint Validation of an algorithm for predicting cardiac events in renal transplant candidates
    Michael S Lewis
    Division of Cardiology, Oregon Health Sciences University, Portland, Oregon 97201, USA
    Am J Cardiol 89:847-50. 2002
    ..Pretransplant risk stratification by clinical variables identified low-risk patients who may not require further cardiac evaluation and high-risk patients with normal SPECT imaging who may not require angiography...
  19. ncbi request reprint Relationship between elevated serum troponin values in end-stage renal disease patients and abnormal isotopic cardiac scans following stress
    George A Porter
    Division of Nephrology, Hypertension and Clinical Pharmacology, PP 262 Department of Medicine, Oregon Health Sciences University, Portland, Oregon, USA
    Ren Fail 25:55-65. 2003
    ..A cTnT > 0.1 microgram/L increases the likelihood of finding significant coronary artery disease three fold in high-risk ESRD patients being evaluated for renal transplantation...
  20. ncbi request reprint Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease
    Vicente E Torres
    Mayo Clinic College of Medicine, Rochester, MN 55901, USA
    Clin J Am Soc Nephrol 2:112-20. 2007
    ..TKV and RBF were independent predictors of GFR decline (functional disease progression). In ADPKD, RBF reduction (1) parallels TKV increase, (2) precedes GFR decline, and (3) predicts structural and functional disease progression...
  21. ncbi request reprint Comparison of methods for determining renal function decline in early autosomal dominant polycystic kidney disease: the consortium of radiologic imaging studies of polycystic kidney disease cohort
    Andrew D Rule
    Division of Nephrology, Mayo Foundation, 200 First Street SW, Rochester, MN 55905, and University of Alabama, Birmingham, USA
    J Am Soc Nephrol 17:854-62. 2006
    ..Misclassification from changes in non-GFR factors (e.g., creatinine production, tubular secretion) conservatively biased associations with eGFR. Misclassification from method imprecision attenuated associations with creatinine clearance...
  22. ncbi request reprint Pirfenidone treatment decreases transforming growth factor-beta1 and matrix proteins and ameliorates fibrosis in chronic cyclosporine nephrotoxicity
    Fuad S Shihab
    Division of Nephrology, University of Utah Health Sciences Center, Salt Lake City, USA
    Am J Transplant 2:111-9. 2002
    ..These experiments suggest that PFD can be clinically useful for preventing chronic CsA nephrotoxicity and may prove to be helpful in other progressive renal diseases...
  23. ncbi request reprint Reversibility of chronic cyclosporine nephropathy in rats after withdrawal of cyclosporine
    Can Li
    Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea
    Am J Physiol Renal Physiol 284:F389-98. 2003
    ..01). These findings suggest that OPN expression and macrophage infiltration decrease after long-term CsA withdrawal in rats with established chronic CsA nephropathy, and this is closely associated with recovery from renal injury...
  24. ncbi request reprint Nitric oxide modulates vascular endothelial growth factor and receptors in chronic cyclosporine nephrotoxicity
    Fuad S Shihab
    Division of Nephrology, University of Utah Health Sciences Center, Salt Lake City, Utah 84132, USA
    Kidney Int 63:522-33. 2003
    ..We examined the role of nitric oxide modulation on VEGF in this model...
  25. ncbi request reprint Cyclosporin induces renal proto-oncogene RNA message and increased transforming growth factor-beta prior to renal fibrosis: Modification by calcium channel blockade in the salt replete rat
    Subodh J Saggi
    Division of Nephrology, Staten Island University Hospital, Staten Island, New York, USA
    Nephrology (Carlton) 9:58-64. 2004
    ..Chronic cyclosporin (CsA) administration has been shown to result in the replacement of epithelial cells in the kidney with fibrous tissue. These changes are kidney-specific, as they do not occur in any other organ...
  26. ncbi request reprint Immunosuppression with mycophenolic acid: one size does not fit all
    William M Bennett
    J Am Soc Nephrol 14:2414-6. 2003
  27. ncbi request reprint Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort
    Kyongtae T Bae
    Department of Radiology, Washington University School of Medicine, St Louis, MO 63110, USA
    Clin J Am Soc Nephrol 1:64-9. 2006
    ..Hepatic cysts are more prevalent and larger in total cyst volume in women than in men. Hepatic cyst prevalence and aggregate total hepatic cyst volume increased with age...
  28. ncbi request reprint Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort
    Arlene B Chapman
    Department of Medicine Renal Division, University of Alabama at Birmingham, Birmingham, Alabama, USA
    Kidney Int 64:1035-45. 2003
    ....
  29. ncbi request reprint Immunosuppression: practice and trends
    J Harold Helderman
    Vanderbilt University, Nashville, TN, USA
    Am J Transplant 3:41-52. 2003
  30. ncbi request reprint Administration of tobramycin in the beginning of the hemodialysis session: a novel intradialytic dosing regimen
    Osama Hussein Kamel Mohamed
    Faculty of Pharmacy, Pharmaceutics Department, Cairo University, Cairo, Egypt
    Clin J Am Soc Nephrol 2:694-9. 2007
    ....
  31. ncbi request reprint Sirolimus increases transforming growth factor-beta1 expression and potentiates chronic cyclosporine nephrotoxicity
    Fuad S Shihab
    Division of Nephrology, University of Utah School of Medicine, Salt Lake City, Utah 84132, USA
    Kidney Int 65:1262-71. 2004
    ..We investigated the effect of combining CsA and SRL on renal structure and function and on transforming growth factor-beta1 (TGF-beta1) and extracellular matrix (ECM) proteins in a model of chronic CsA nephrotoxicity...
  32. ncbi request reprint Response to "Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared with lisinopril"
    Titte R Srinivas
    Transplantation 74:139; author reply 139-40. 2002
  33. ncbi request reprint Expression of apoptosis-related genes in chronic cyclosporine nephrotoxicity in mice
    Chul Woo Yang
    Division of Nephrology, Catholic University of Korea, Seoul, Korea
    Am J Transplant 2:391-9. 2002
    ..These findings suggest that local activation of the apoptosis-related genes is associated with CsA-induced apoptotic cell death...
  34. ncbi request reprint Effect of cyclosporine and sirolimus on the expression of connective tissue growth factor in rat experimental chronic nephrotoxicity
    Fuad S Shihab
    Division of Nephrology, University of Utah School of Medicine, Salt Lake City, UT 84132, USA
    Am J Nephrol 26:400-7. 2006
    ..However, CTGF regulation remains unknown. We tried to determine the effect of two commonly used immunosuppressants, cyclosporine (CsA) and sirolimus (SRL), on CTGF expression in a model of chronic nephrotoxicity...
  35. ncbi request reprint Combination therapy with sirolimus and mycophenolate mofetil: effects on the kidney and on transforming growth factor-beta1
    Fuad S Shihab
    Division of Nephrology, University of Utah School of Medicine, Salt Lake City, Utah, USA
    Transplantation 77:683-6. 2004
    ..The long-term consequence of increased TGF-beta in SRL-treated kidneys remains unknown. However, because MMF can reverse this trend, SRL and MMF combination therapy may be protective...
  36. ncbi request reprint Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients
    Rami T Bustami
    Scientific Registry of Transplant Recipients University Renal Research and Education Association, Ann Arbor, MI, USA
    Am J Transplant 4:87-93. 2004
    ..024). These new estimates of the magnitude of malignancy risk associated with induction therapy may be useful for clinical practice...
  37. ncbi request reprint Iron sucrose in hemodialysis patients: safety of replacement and maintenance regimens
    George R Aronoff
    University of Louisville School of Medicine, Louisville, Kentucky, USA
    Kidney Int 66:1193-8. 2004
    ..This multicenter phase IV clinical trial examined the safety of iron sucrose for the treatment of iron deficiency and for the maintenance of iron sufficiency in hemodialysis patients...
  38. ncbi request reprint Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease
    Bernard F King
    Department of Medicine Renal Division, University of Alabama, Birmingham, Alabama, USA
    Kidney Int 64:2214-21. 2003
    ..Despite evidence for the importance of nephroangiosclerosis in the progression of renal insufficiency in ADPKD, evaluation of renal blood flow (RBF) as a surrogate marker of disease severity has received little attention...
  39. ncbi request reprint Cardiovascular complications of immunosuppressive agents in renal transplant recipients
    Ali J Olyaei
    Oregon Health Sciences University, Division of Nephrology, Hypertension, 3181 SW Sam Jackson Park Road, Mail Code CR9 4 Portland, Oregon 97201, USA
    Expert Opin Drug Saf 4:29-44. 2005
    ..Adverse reactions and drug-drug interactions should not be neglected when selecting an agent for treatment of cardiovascular risk factors in transplant recipients...
  40. ncbi request reprint Effect of pirfenidone on apoptosis-regulatory genes in chronic cyclosporine nephrotoxicity
    Fuad S Shihab
    Division of Nephrology, University of Utah School of Medicine, 30 N 1900 E, Salt Lake City, UT 84132, USA
    Transplantation 79:419-26. 2005
    ..In addition, the antifibrotic molecule pirfenidone (PFD) was shown to ameliorate fibrosis in this model. We evaluated the role of PFD on the expression of apoptosis-regulatory genes in the kidneys of CsA-treated rats...
  41. ncbi request reprint Current status of kidney and pancreas transplantation in the United States, 1994-2003
    Gabriel M Danovitch
    David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA
    Am J Transplant 5:904-15. 2005
    ..The percentage of Hispanic/Latino recipients increased from 5% to 9% over the same period...
  42. ncbi request reprint The failed renal transplant: in or out?
    William M Bennett
    Semin Dial 18:188-9. 2005
    ..The author's personal approach is presented...
  43. ncbi request reprint Mycophenolate mofetil ameliorates arteriolopathy and decreases transforming growth factor-beta1 in chronic cyclosporine nephrotoxicity
    Fuad S Shihab
    Division of Nephrology, University of Utah School of Medicine, Salt Lake City, USA
    Am J Transplant 3:1550-9. 2003
    ..While this drug combination may be useful clinically, long-term studies are needed to determine if MMF has a lasting benefit...
  44. ncbi request reprint Volume progression in polycystic kidney disease
    Jared J Grantham
    Kidney Institute and the Department of Internal Medicine, Kansas University Medical Center, Kansas City, KS 66160, USA
    N Engl J Med 354:2122-30. 2006
    ..Autosomal dominant polycystic kidney disease (ADPKD) is characterized by progressive enlargement of cyst-filled kidneys...
  45. ncbi request reprint Angiotensin II regulation of vascular endothelial growth factor and receptors Flt-1 and KDR/Flk-1 in cyclosporine nephrotoxicity
    Fuad S Shihab
    Division of Nephrology, University of Utah Health Sciences Center, Salt Lake City, Utah 84132, USA
    Kidney Int 62:422-33. 2002
    ..We have previously shown that VEGF is up-regulated in a chronic cyclosporine (CsA) nephrotoxicity model. Our current study examined the role of angiotensin II (Ang II) blockade with enalapril (E) or losartan (L) on VEGF in this model...